ELIXIR Slovenia Node team up with experts from EMBL-EBI to help create a Centre for Excellence in Translational Medicine (CETM). Through the ARTEMIDA project which has recently been awarded highly-prized grants from the Horizon 2020 WIDESPREAD Teaming Call, partners will develop an integrated research and innovation cluster in translational medicine for Central and South-East Europe. Led by the University of Ljubljana, which will act as the lead partner in Slovenia's ELIXIR Node, ARTEMIDA will allow insight and expertise in data management from staff at EMBL-EBI to be integrated into the CETM. The project will also see expertise in translational medicine provided by Karolinska Institute in Sweden.
On November 15, 2011 President of the Republic of Slovenia visited Institute of Biochemistry, CFGBC and a spin-off company DiaGenomi, where he discussed the achievements of Slovenian researchers in the field of medicine and genetics.